706 related articles for article (PubMed ID: 17592264)
1. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
2. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
3. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.
Gunderson CC; Dutta S; Fader AN; Maniar KP; Nasseri-Nik N; Bristow RE; Diaz-Montes TP; Palermo R; Kurman RJ
Gynecol Oncol; 2014 Jan; 132(1):33-7. PubMed ID: 24316307
[TBL] [Abstract][Full Text] [Related]
4. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
5. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Mentrikoski MJ; Shah AA; Hanley KZ; Atkins KA
Am J Clin Pathol; 2012 Oct; 138(4):524-34. PubMed ID: 23010707
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
[TBL] [Abstract][Full Text] [Related]
7. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
8. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
Penner KR; Dorigo O; Aoyama C; Ostrzega N; Balzer BL; Rao J; Walsh CS; Cass I; Holschneider CH
Gynecol Oncol; 2012 Mar; 124(3):542-8. PubMed ID: 22079678
[TBL] [Abstract][Full Text] [Related]
9. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
[TBL] [Abstract][Full Text] [Related]
10. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
11. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia.
Miranda MC; Mazur MT
Arch Pathol Lab Med; 1995 May; 119(5):458-60. PubMed ID: 7748076
[TBL] [Abstract][Full Text] [Related]
12. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
13. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
Gong Q; Chen X; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
[TBL] [Abstract][Full Text] [Related]
14. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.
Amezcua CA; Zheng W; Muderspach LI; Felix JC
Gynecol Oncol; 1999 Apr; 73(1):126-36. PubMed ID: 10094893
[TBL] [Abstract][Full Text] [Related]
17. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience].
Ivanov S; Kovachev E; Tsonev A; Abbud A
Akush Ginekol (Sofiia); 2010; 49(2):47-9. PubMed ID: 20734678
[TBL] [Abstract][Full Text] [Related]
18. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study.
Rattanachaiyanont M; Angsuwathana S; Techatrisak K; Tanmahasamut P; Indhavivadhana S; Leerasiri P
J Obstet Gynaecol Res; 2005 Apr; 31(2):98-106. PubMed ID: 15771634
[TBL] [Abstract][Full Text] [Related]
20. Microcarcinoma of the endometrium: a mapping study with special reference to cytologic atypia in the endometrium.
Hachisuga T; Sugimori H; Kaku T; Tsuneyoshi M
Jpn J Clin Oncol; 1992 Dec; 22(6):400-5. PubMed ID: 1291756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]